Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Wanhua Chemical Group Co Ltd | 2 |
| 2 | Consortium fuer Elektrochemische Industrie GmbH | 1 |
| 3 | Sony Group Corp | 1 |
| 4 | University of California, San Diego | 1 |
| 5 | University of Florida | 1 |
Where innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 16 |
| 2 | A61P | Therapeutic activity (drug indications) | 12 |
| 3 | C07D | Heterocyclic compounds | 10 |
| 4 | G01N | Investigating / analysing materials | 7 |
| 5 | Y02P | Climate change mitigation: production | 7 |
| 6 | Y02A | Climate change adaptation | 6 |
| 7 | C07C | Acyclic and carbocyclic compounds | 5 |
| 8 | B01J | Chemical/physical processes (e.g. catalysts) | 4 |
| 9 | C07B | General methods of organic chemistry | 4 |
| 10 | C07F | Organometallic compounds | 4 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Process for extracting salsoline from Common Russianthistle Herb | 2012 | Nanjing Zelang Medical Technology Co., Ltd. | 0 |
| Method extracting salsoline A from salsola collina | 2012 | Nanjing Zelang Medical Technology Co., Ltd. | 0 |
| Preparation method of salsoline | 2011 | Nanjing Zelang Medical Technology Co., Ltd. | 0 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Cell death mechanisms and regulation | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Makoto Naoi | Institute of Applied Biochemistry | 30 |
| 2 | Wakako Maruyama | National Center for Geriatrics and Gerontology | 20 |
| 3 | W. Maruyama | National Center for Geriatrics and Gerontology | 11 |
| 4 | P. Dostert | Structure Fédérative de Recherche en Biologie et Santé de Rennes | 10 |
| 5 | Tsutomu Takahashi | Aichi Konan College | 8 |
| 6 | Hong Yi | National Institute of Biotechnology | 7 |
| 7 | Yukihiro Akao | National Institute of Biotechnology | 7 |
| 8 | Yulin Deng | Nagoya Institute of Technology | 7 |
| 9 | Masao Kawai | Nagoya Institute of Technology | 3 |
| 10 | Moussa B. H. Youdim | Technion – Israel Institute of Technology | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Cell death of dopamine neurons in aging and Parkinson’s disease | 1999 | 131 | Neuroscience and Neuropharmacology Research |
| Dopamine-derived endogenous N-methyl-(R)-salsolinol | 2002 | 103 | Neuroscience and Neuropharmacology Research |
| A dopaminergic neurotoxin, (<i>R</i>)‐N‐methylsalsolinol, increases in parkinsonian cerebrospinal fluid | 1996 | 103 | Neuroscience and Neuropharmacology Research |
| A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain | 1997 | 101 | Neurotransmitter Receptor Influence on Behavior |
| Assay for the (R)- and (S)-enantiomers of salsolinols in biological samples and foods with ion-pair high-performance liquid chromatography using β-cyclodextrin as a chiral mobile phase additive | 1997 | 59 | Analytical Chemistry and Chromatography |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Salsoline?
Which authors have published the most research on Salsoline?
What are the main patent classification areas for Salsoline-related patents?
What major research topics are associated with Salsoline in the literature?
Which organizations hold patents for Salsoline preparation and extraction?